Results 121 to 130 of about 8,420 (208)
Çalışmamızda antihipertansif etkili ilaç etken maddeleri, Olmesartan medoksomil ve Hidroklorotiyazid ve bu etken maddelerin safsızlıklarının aynı anda tayinleri amacıyla bir Agilent 1100 serisi HPLC yöntemi geliştirilmiş ve valide edilmiştir.
SAÇINTI, Çağlar
core
Hajra Parveen, Vanitha Kondi, R. Alluri
semanticscholar +1 more source
Luis M RuilopeUnidad de Hipertensión, Hospital 12 de Octubre, Madrid, SpainAbstract: Hypertension is a major risk factor for cardiovascular disease that contributes to the premature death of millions of people each year, and identification and ...
Luis M Ruilope
doaj
A Thermoresponsive In Situ Salified Self-Nanoemulsifying Drug Delivery System of Olmesartan Medoxomil: Overcoming Leakage and Drug Trapping Limitations. [PDF]
Sherif AY, Altamimi MA, Elzayat EM.
europepmc +1 more source
Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action. [PDF]
Arun JK +3 more
europepmc +1 more source
Optimization, Ex-Vivo Penetration and In-Vivo Evaluation of Pegylated Nanostructured Lipid Carriers of Olmesartan Medoxomil to Enhance Transdermal Delivery. [PDF]
Albash R +3 more
europepmc +1 more source
Olmesartan medoxomil (OLMD) is a selective AT1 subtype angiotensin II receptor antagonist 1,2. Hydrochlorothiazide (HCT) is a thiazide diuretic that is commonly used in combination with other antihypertensive agents 3.
core
Synthesis of related substances of olmesartan medoxomil, an anti-hypertensive drug
Karrothu S. Babu +5 more
doaj +1 more source
Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice. [PDF]
Zhu Y +7 more
europepmc +1 more source

